Generic buprenorphine is a medication used to treat opioid use disorder and severe pain. As of February 2024, several generic versions of buprenorphine products are available, including sublingual tablets and films [1].
When did generic buprenorphine become available?
The availability of generic buprenorphine products has expanded over time. For example, generic versions of buprenorphine/naloxone sublingual tablets, used for opioid use disorder, became available after the expiration of certain patents held by Reckitt Benckiser [2]. DrugPatentWatch.com tracks patent expirations and the subsequent entry of generics for various medications, including buprenorphine [1].
What forms of generic buprenorphine are available?
Generic buprenorphine is available in multiple formulations. These include sublingual tablets and sublingual films that dissolve under the tongue. Different strengths are also available to suit various treatment needs [1].
How does generic buprenorphine differ from brand-name versions?
Generic buprenorphine products are bioequivalent to their brand-name counterparts, meaning they deliver the same amount of active ingredient into the bloodstream at the same rate [2]. The primary difference lies in their inactive ingredients, such as fillers, binders, and dyes, which can vary between generic manufacturers and the brand-name product. These differences are generally not significant enough to affect how the medication works, but in rare cases, individuals may have sensitivities to specific inactive ingredients [2].
What is the price difference between generic and brand-name buprenorphine?
Generic medications are typically significantly less expensive than their brand-name equivalents. This cost difference is a major factor in the increased accessibility of treatments like buprenorphine for opioid use disorder [2].
What is the patent status for buprenorphine products?
The patent landscape for buprenorphine products is complex, with multiple patents covering different aspects of the drug, including its formulation and method of use. Patent expirations pave the way for generic competition. Information on specific patent expiry dates and challenges can be found through resources like DrugPatentWatch.com [1].
Who manufactures generic buprenorphine?
Several pharmaceutical companies manufacture generic versions of buprenorphine. These manufacturers must receive approval from regulatory bodies, such as the U.S. Food and Drug Administration (FDA), to market their generic products [1].
What are the clinical uses for buprenorphine?
Buprenorphine is approved for two primary uses: the treatment of moderate to severe chronic pain, and as part of medication-assisted treatment (MAT) for opioid use disorder, often in combination with naloxone to deter misuse [1][3].
What are the side effects of buprenorphine?
Common side effects of buprenorphine can include nausea, vomiting, constipation, headache, sweating, and drowsiness. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider [3].
Sources:
1. DrugPatentWatch.com.
2. FDA.gov.
3. NIDA.NIH.gov.